Cancer cell growth inhibitory effect of bee venom via increase of death receptor 3 expression and inactivation of NF-kappa B in NSCLC cells

• Published in: Toxins 2014-07, Vol.6 (8), p.2210-2228
• Main Authors: Choi, Kyung Eun, Hwang, Chul Ju, Gu, Sun Mi, Park, Mi Hee, Kim, Joo Hwan, Park, Joo Ho, Ahn, Young Jin, Kim, Ji Young, Song, Min Jong, Song, Ho Sueb, Han, Sang-Bae, Hong, Jin Tae
• Format: Article
• Language: English
• Subjects: Antineoplastic Agents - pharmacology; apoptosis; Apoptosis - drug effects; bee venom; Bee Venoms - pharmacology; Carcinoma, Non-Small-Cell Lung - metabolism; Cell Line, Tumor; Cell Survival - drug effects; death receptors; Humans; Inactivation; Lung cancer; Lung Neoplasms - metabolism; Mortality; NF-kappa B - antagonists & inhibitors; NF-kappa B - metabolism; NF-κB; Receptors, Tumor Necrosis Factor, Member 25 - metabolism
• ISSN: 2072-6651; 2072-6651
• DOI: 10.3390/toxins6082210

Our previous findings have demonstrated that bee venom (BV) has anti-cancer activity in several cancer cells. However, the effects of BV on lung cancer cell growth have not been reported. Cell viability was determined with trypan blue uptake, soft agar formation as well as DAPI and TUNEL assay. Cell death related protein expression was determined with Western blotting. An EMSA was used for nuclear factor kappaB (NF-κB) activity assay. BV (1-5 μg/mL) inhibited growth of lung cancer cells by induction of apoptosis in a dose dependent manner in lung cancer cell lines A549 and NCI-H460. Consistent with apoptotic cell death, expression of DR3 and DR6 was significantly increased. However, deletion of DRs by small interfering RNA significantly reversed BV induced cell growth inhibitory effects. Expression of pro-apoptotic proteins (caspase-3 and Bax) was concomitantly increased, but the NF-κB activity and expression of Bcl-2 were inhibited. A combination treatment of tumor necrosis factor (TNF)-like weak inducer of apoptosis, TNF-related apoptosis-inducing ligand, docetaxel and cisplatin, with BV synergistically inhibited both A549 and NCI-H460 lung cancer cell growth with further down regulation of NF-κB activity. These results show that BV induces apoptotic cell death in lung cancer cells through the enhancement of DR3 expression and inhibition of NF-κB pathway.